Revenue Recognition and Collaborative Arrangements (Tables)

3 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of net revenue from collaborative arrangements

Net revenue recognized under our GSK Agreements was as follows:

	Three Months Ended March 31,
(In thousands)	2022			2021
Royalties from a related party    - RELVAR/BREO	$	55,764		$	56,390
Royalties from a related party    - ANORO		8,442			10,500
Royalties from a related party    - TRELEGY		29,309			22,084
Total royalties from a related party		93,515			88,974
Less: amortization of capitalized fees    paid to a related party		(3,456	)		(3,456	)
Royalty revenue from GSK	$	90,059		$	85,518